Clinical Trials Browser

Phase 1 × dabrafenib × CNS × Clear all

NCT05388877 2025-08-19

E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma

Phase 1 Terminated

CNSDermatologic

Brain Neoplasms, Melanoma

NCT03332589 2022-05-20

E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)

Phase 1 Terminated

4 enrolled 9 charts

CNSDermatologic

Brain Neoplasms, Melanoma